👨 Testosterone Replacement Therapy Eligibility Simulator

Symptom Criteria for Hypogonadism

Placeholder: core symptoms guide initial suspicion of low testosterone.

• Low libido: Key symptom (Placeholder short note)
• Fatigue: Key symptom (Placeholder short note)
• Mood change: Key symptom (Placeholder short note)
• ≥3 symptoms: Threshold (Placeholder short note)

Recognizing symptom patterns

Placeholder: clinicians review symptom checklist before ordering labs.

Placeholder: symptoms alone never confirm diagnosis without labs.

Two Confirmed Morning Low-Testosterone Readings

Placeholder: diagnosis requires two separate morning total testosterone draws.

• AM only: Draw time (Placeholder short note)
• <300 ng/dL: Cutoff (Placeholder short note)
• 2 required: Repeat draws (Placeholder short note)
• Total T: Assay (Placeholder short note)

Why two readings matter

Placeholder: single low value can be transient or lab error.

Placeholder: confirmed low readings anchor the diagnosis.

Ruling Out Reversible Causes

Placeholder: exclude pituitary, thyroid, medication, and lifestyle factors.

• Pituitary: Check (Placeholder short note)
• Thyroid: Check (Placeholder short note)
• Medications: Check (Placeholder short note)
• Obesity/sleep: Check (Placeholder short note)

Secondary cause workup

Placeholder: labs and history screen for reversible contributors.

Placeholder: treating underlying cause may resolve low testosterone.

Shared Decision-Making on Risks

Placeholder: patient and clinician weigh benefits against known risks.

• Cardiovascular: Risk (Placeholder short note)
• Fertility: Risk (Placeholder short note)
• Prostate: Risk (Placeholder short note)
• Polycythemia: Risk (Placeholder short note)

Discussing tradeoffs

Placeholder: informed consent covers monitoring and side effects.

Placeholder: shared decisions respect patient goals and risk tolerance.

Candidacy Determination

Placeholder: final eligibility combines labs, symptoms, and consent.

• Eligible: Outcome (Placeholder short note)
• Not eligible: Outcome (Placeholder short note)
• Further workup: Outcome (Placeholder short note)
• 3 months: Follow-up (Placeholder short note)

Final determination

Placeholder: eligibility recommendation issued after full review.

Placeholder: ongoing monitoring follows any therapy decision.